coumarin has been researched along with Prostatic Hyperplasia in 1 studies
2H-chromen-2-one: coumarin derivative
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Descazeaud, A | 1 |
| Robert, G | 1 |
| Azzousi, AR | 1 |
| Ballereau, C | 1 |
| Lukacs, B | 1 |
| Haillot, O | 1 |
| Dumonceau, O | 1 |
| Devonec, M | 1 |
| Fourmarier, M | 1 |
| Saussine, C | 1 |
| de la Taille, A | 1 |
1 review available for coumarin and Prostatic Hyperplasia
| Article | Year |
|---|---|
Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review.
Topics: Anticoagulants; Blood Loss, Surgical; Coumarins; Heparin, Low-Molecular-Weight; Humans; Laser Therap | 2009 |